Treatment-wise Glioblastoma Survival Inference with Multi-parametric Preoperative MRI.

Xiaofeng Liu, Nadya Shusharina, Helen A Shih, C-C Jay Kuo, Georges El Fakhri, Jonghye Woo
{"title":"Treatment-wise Glioblastoma Survival Inference with Multi-parametric Preoperative MRI.","authors":"Xiaofeng Liu, Nadya Shusharina, Helen A Shih, C-C Jay Kuo, Georges El Fakhri, Jonghye Woo","doi":"10.1117/12.3006897","DOIUrl":null,"url":null,"abstract":"<p><p>In this work, we aim to predict the survival time (ST) of glioblastoma (GBM) patients undergoing different treatments based on preoperative magnetic resonance (MR) scans. The personalized and precise treatment planning can be achieved by comparing the ST of different treatments. It is well established that both the current status of the patient (as represented by the MR scans) and the choice of treatment are the cause of ST. While previous related MR-based glioblastoma ST studies have focused only on the direct mapping of MR scans to ST, they have not included the underlying causal relationship between treatments and ST. To address this limitation, we propose a treatment-conditioned regression model for glioblastoma ST that incorporates treatment information in addition to MR scans. Our approach allows us to effectively utilize the data from all of the treatments in a unified manner, rather than having to train separate models for each of the treatments. Furthermore, treatment can be effectively injected into each convolutional layer through the adaptive instance normalization we employ. We evaluate our framework on the BraTS20 ST prediction task. Three treatment options are considered: Gross Total Resection (GTR), Subtotal Resection (STR), and no resection. The evaluation results demonstrate the effectiveness of injecting the treatment for estimating GBM survival.</p>","PeriodicalId":74505,"journal":{"name":"Proceedings of SPIE--the International Society for Optical Engineering","volume":"12927 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11497473/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of SPIE--the International Society for Optical Engineering","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1117/12.3006897","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In this work, we aim to predict the survival time (ST) of glioblastoma (GBM) patients undergoing different treatments based on preoperative magnetic resonance (MR) scans. The personalized and precise treatment planning can be achieved by comparing the ST of different treatments. It is well established that both the current status of the patient (as represented by the MR scans) and the choice of treatment are the cause of ST. While previous related MR-based glioblastoma ST studies have focused only on the direct mapping of MR scans to ST, they have not included the underlying causal relationship between treatments and ST. To address this limitation, we propose a treatment-conditioned regression model for glioblastoma ST that incorporates treatment information in addition to MR scans. Our approach allows us to effectively utilize the data from all of the treatments in a unified manner, rather than having to train separate models for each of the treatments. Furthermore, treatment can be effectively injected into each convolutional layer through the adaptive instance normalization we employ. We evaluate our framework on the BraTS20 ST prediction task. Three treatment options are considered: Gross Total Resection (GTR), Subtotal Resection (STR), and no resection. The evaluation results demonstrate the effectiveness of injecting the treatment for estimating GBM survival.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用多参数术前磁共振成像推断胶质母细胞瘤的治疗生存期
在这项研究中,我们旨在根据术前磁共振(MR)扫描结果预测接受不同治疗的胶质母细胞瘤(GBM)患者的生存时间(ST)。通过比较不同治疗方法的存活时间,可以实现个性化和精确的治疗规划。患者目前的状况(由磁共振扫描显示)和治疗方法的选择都是导致 ST 的原因,这一点已得到公认。以往基于磁共振成像的相关胶质母细胞瘤ST研究只关注磁共振扫描与ST的直接映射,而没有包括治疗与ST之间的内在因果关系。为了解决这一局限性,我们提出了一种以治疗为条件的胶质母细胞瘤ST回归模型,该模型除了包含磁共振扫描信息外,还包含了治疗信息。我们的方法使我们能够以统一的方式有效利用所有治疗方法的数据,而不必为每种治疗方法训练单独的模型。此外,通过我们采用的自适应实例归一化,治疗可以有效地注入到每个卷积层中。我们在 BraTS20 ST 预测任务中对我们的框架进行了评估。我们考虑了三种治疗方案:全切除术(GTR)、次全切除术(STR)和不切除术。评估结果表明,注入治疗方案对估计 GBM 存活率非常有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.50
自引率
0.00%
发文量
0
期刊最新文献
Automated multi-lesion annotation in chest X-rays: annotating over 450,000 images from public datasets using the AI-based Smart Imagery Framing and Truthing (SIFT) system. High-Fidelity 3D Reconstruction for Accurate Anatomical Measurements in Endoscopic Sinus Surgery. Optimizing parylene and photoconductor thickness in indirect conversion amorphous selenium detectors. Intra- and inter-scanner CT variability and their impact on diagnostic tasks. Quantitative Accuracy of CT Protocols for Cross-sectional and Longitudinal Assessment of COPD: A Virtual Imaging Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1